{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:08:37Z","timestamp":1791212917577,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinical-lymphoma-myeloma-leukemia.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.clml.2015.02.001","type":"journal-article","created":{"date-parts":[[2015,2,11]],"date-time":"2015-02-11T03:57:23Z","timestamp":1423627043000},"page":"420-427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Second Cancers and Richter Transformation Are the Leading Causes of Death in Patients With Trisomy 12 Chronic Lymphocytic Leukemia"],"prefix":"10.1016","volume":"15","author":[{"given":"Paolo","family":"Strati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne V.","family":"Abruzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Wierda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Ferrajoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Keating","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2015.02.001_bib1","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1038\/sj.leu.2404935","article-title":"Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping","volume":"21","author":"Haferlach","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2015.02.001_bib2","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia","volume":"343","author":"Dohner","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2015.02.001_bib3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1600-0609.2010.01454.x","article-title":"The clinical and biological features of a series of immunophenotypic variant of B-CLL","volume":"85","author":"Cro","year":"2010","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clml.2015.02.001_bib4","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1046\/j.1365-2141.1996.d01-1478.x","article-title":"Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients","volume":"92","author":"Matutes","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2015.02.001_bib5","doi-asserted-by":"crossref","first-page":"561","DOI":"10.5858\/2003-127-0561-CEICLL","article-title":"CD79b expression in chronic lymphocytic leukemia. Association with trisomy 12 and atypical immunophenotype","volume":"127","author":"Schlette","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.clml.2015.02.001_bib6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/cyto.b.20390","article-title":"Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia","volume":"74","author":"Quijano","year":"2008","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.clml.2015.02.001_bib7","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3324\/haematol.2011.060129","article-title":"NOTCH1 mutations in\u00a0+12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of\u00a0+12 CLL","volume":"97","author":"Del Giudice","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2015.02.001_bib8","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1309\/AJCPOEFP3SLX6HXJ","article-title":"Chronic lymphocytic leukemia with t(14; 19)(q32; q13) is characterized by atypical morphologic and immunophenotypic features and distinctive genetic features","volume":"135","author":"Huh","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clml.2015.02.001_bib9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2141.2007.06636.x","article-title":"Trisomy 19 is associated with trisomy 12 and mutated IGHV genes in B-chronic lymphocytic leukaemia","volume":"138","author":"Sellmann","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2015.02.001_bib10","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.leukres.2009.11.003","article-title":"Increased trisomy 12 frequency and a biased IgVH 3-21 gene usage characterize small lymphocytic lymphoma","volume":"34","author":"Daudignon","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.clml.2015.02.001_bib11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s11899-007-0036-9","article-title":"Richter's transformation in chronic lymphocytic leukemia","volume":"2","author":"Tsimberidou","year":"2007","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.clml.2015.02.001_bib12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1365-2141.2008.07166.x","article-title":"Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome","volume":"142","author":"Rossi","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2015.02.001_bib13","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1182\/blood-2013-03-489518","article-title":"Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome","volume":"122","author":"Chigrinova","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.clml.2015.02.001_bib14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/hon.2086","article-title":"B-cell receptor configuration and mutational analysis of patients with chronic lymphocytic leukaemia and trisomy 12 reveal recurrent molecular abnormalities","volume":"32","author":"Falisi","year":"2014","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.clml.2015.02.001_bib15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1182\/blood-2011-10-386144","article-title":"NOTCH1 mutations in CLL associated with trisomy 12","volume":"119","author":"Balatti","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clml.2015.02.001_bib16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature10113","article-title":"Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia","volume":"475","author":"Puente","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.clml.2015.02.001_bib17","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/gcc.21972","article-title":"Different distribution of NOTCH1 mutations in chronic lymphocytic leukemia with isolated trisomy 12 or associated with other chromosomal alterations","volume":"51","author":"Lopez","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.clml.2015.02.001_bib18","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1182\/blood.V81.10.2702.2702","article-title":"Fluorescent in situ hybridization and cytogenetic studies of trisomy 12 in chronic lymphocytic leukemia","volume":"81","author":"Escudier","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.clml.2015.02.001_bib19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cancergencyto.2006.02.001","article-title":"Clinical, immunophenotypic, and molecular profiling of trisomy 12 in chronic lymphocytic leukemia and comparison with other karyotypic subgroups defined by cytogenetic analysis","volume":"168","author":"Athanasiadou","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.clml.2015.02.001_bib20","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1182\/blood.V82.2.571.571","article-title":"Trisomy 12 in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: analysis by stage, immunophenotype, and morphology","volume":"82","author":"Que","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.clml.2015.02.001_bib21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/cyto.990220309","article-title":"Clinical, biological, and immunophenotypical characteristics of B-cell chronic lymphocytic leukemia with trisomy 12 by fluorescence in situ hybridization","volume":"22","author":"Tabernero","year":"1995","journal-title":"Cytometry"},{"key":"10.1016\/j.clml.2015.02.001_bib22","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","article-title":"Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute\u2014Working Group 1996 guidelines","volume":"111","author":"Hallek","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clml.2015.02.001_bib23","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1182\/blood.V87.12.4990.bloodjournal87124990","article-title":"National Cancer Institute\u2013Sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment","volume":"87","author":"Cheson","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.clml.2015.02.001_bib24","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1200\/JCO.2006.06.9492","article-title":"Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia","volume":"24","author":"Shanafelt","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2015.02.001_bib25","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa040857","article-title":"ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia","volume":"351","author":"Rassenti","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2015.02.001_bib26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cancergen.2010.12.006","article-title":"Enhanced detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide in combination with pokeweed mitogen and phorbol myristate acetate","volume":"204","author":"Muthusamy","year":"2011","journal-title":"Cancer Genet"},{"key":"10.1016\/j.clml.2015.02.001_bib27","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1365-2141.1994.tb08307.x","article-title":"Trisomy 12 is uncommon in typical chronic lymphocytic leukaemias","volume":"87","author":"Criel","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2015.02.001_bib28","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1365-2141.1997.402686.x","article-title":"Further characterization of morphologically defined typical and atypical CLL: a clinical, immunophenotypic, cytogenetic and prognostic study on 390 cases","volume":"97","author":"Criel","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2015.02.001_bib29","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/10428190109097682","article-title":"CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia","volume":"42","author":"D'Arena","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2015.02.001_bib30","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1182\/blood-2014-01-552307","article-title":"Trisomy 12 chronic lymphocytic leukemia cells exhibit upregulation of integrin signaling that is modulated by NOTCH1 mutations","volume":"123","author":"Riches","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.clml.2015.02.001_bib31","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00277-013-1967-y","article-title":"The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia","volume":"93","author":"Brachtl","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2015.02.001_bib32","doi-asserted-by":"crossref","first-page":"e66247","DOI":"10.1371\/journal.pone.0066247","article-title":"CD38 structure-based inhibitor design using the 1-cyclic inosine 5\u2032-diphosphate ribose template","volume":"8","author":"Moreau","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clml.2015.02.001_bib33","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2141.2008.07086.x","article-title":"The prognostic significance of cytopenia in chronic lymphocytic leukaemia\/small lymphocytic lymphoma","volume":"141","author":"Zent","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2015.02.001_bib34","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/CCO.0b013e328348c683","article-title":"A\u00a0matter of debate in chronic lymphocytic leukemia: is the occurrence of autoimmune disorders an indicator of chronic lymphocytic leukemia therapy?","volume":"23","author":"Strati","year":"2011","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.clml.2015.02.001_bib35","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.autrev.2013.11.010","article-title":"Diagnosis and classification of autoimmune hemolytic anemia","volume":"13","author":"Bass","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clml.2015.02.001_bib36","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.autrev.2014.01.026","article-title":"Diagnosis and classification of immune-mediated thrombocytopenia","volume":"13","author":"Lo","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clml.2015.02.001_bib37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cancergencyto.2006.07.006","article-title":"Genetic abnormalities and clinical outcome in chronic lymphocytic leukemia","volume":"171","author":"Ripolles","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.clml.2015.02.001_bib38","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/gcc.22176","article-title":"14q deletions are associated with trisomy 12, NOTCH1 mutations and unmutated IGHV genes in chronic lymphocytic leukemia and small lymphocytic lymphoma","volume":"53","author":"Cosson","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.clml.2015.02.001_bib39","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1200\/JCO.2011.36.9348","article-title":"Minimal residual disease quantification is an independent predictor of progression-free and overall survival in chronic lymphocytic leukemia: a multivariate analysis from the randomized GCLLSG CLL8 trial","volume":"30","author":"Bottcher","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2015.02.001_bib40","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1182\/blood-2013-11-538116","article-title":"Eradication of bone marrow minimal residual disease with first-line chemoimmunotherapy may prompt early treatment discontinuation in chronic lymphocytic leukemia","volume":"123","author":"Strati","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.clml.2015.02.001_bib41","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4149\/neo_2011_01_82","article-title":"Cytogenetic abnormalities predict treatment-free interval and response to therapy in previously untreated chronic lymphocytic leukemia patients","volume":"58","author":"Giertlova","year":"2011","journal-title":"Neoplasma"},{"key":"10.1016\/j.clml.2015.02.001_bib42","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/bjh.12458","article-title":"Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients","volume":"162","author":"Parikh","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2015.02.001_bib43","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1200\/JCO.2008.17.5398","article-title":"Other malignancies in chronic lymphocytic leukemia\/small lymphocytic lymphoma","volume":"27","author":"Tsimberidou","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2015.02.001_bib44","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1200\/JCO.2012.43.4449","article-title":"Overall and cancer-specific survival of patients with breast, colon, kidney, and lung cancers with and without chronic lymphocytic leukemia: a SEER population-based study","volume":"31","author":"Solomon","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2015.02.001_bib45","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2141.2008.07012.x","article-title":"Chronic lymphocytic leukaemia CD20 expression is dependent on the genetic subtype: a study of quantitative flow cytometry and fluorescent in-situ hybridization in 510 patients","volume":"141","author":"Tam","year":"2008","journal-title":"Br J Haematol"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265015000300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265015000300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T04:31:47Z","timestamp":1717734707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265015000300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S2152265015000300"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2015.02.001","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Second Cancers and Richter Transformation Are the Leading Causes of Death in Patients With Trisomy 12 Chronic Lymphocytic Leukemia","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2015.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}